Thursday, 3 April 2025
25.7 C
Singapore
28.2 C
Thailand
20.8 C
Indonesia
26.9 C
Philippines

Retro Biosciences, backed by Sam Altman, aims for US$1 billion to revolutionise ageing

Sam Altman backs Retro Biosciencesโ€™ US$1 billion raise to extend lifespan by 10 years, advance longevity technology, and target age-related diseases.

OpenAI CEO Sam Altman is ramping up his investment in Retro Biosciences, a San Francisco-based biotech company that aims to extend the healthy human lifespan by an additional 10 years. As reported by the Financial Times, the company is now raising US$1 billion in a Series A funding round, which Altman is supporting.

Building on a strong foundation

Altman had previously invested an impressive US$180 million in Retro Biosciencesโ€™ entire seed round. His continued backing reflects confidence in the companyโ€™s mission and potential. Retro Biosciences focuses on combating ageing-related diseases and advancing technologies to support longevity.

The startup has made significant strides in its research. Recently, it collaborated with OpenAI to train a model to transform ordinary cells into stem cells. These stem cells hold promise for treating various health conditions, including degenerative diseases like Alzheimerโ€™s.

Speaking to the Financial Times, Retro Biosciences CEO Joe Betts-LaCroix emphasised the urgency of their mission. He expressed a clear goal: to discover and develop a life-changing drug before the decade is over. “We want to move fast,” Betts-LaCroix said.

Billionaire-backed longevity movement

Retro Biosciences isnโ€™t alone in the race to extend human life. Several other billionaire-funded initiatives are working on similar goals. One of the most prominent examples is Altos Labs, launched in 2022 with US$3 billion in funding, backed by Amazon founder Jeff Bezos. Unity Biotechnology, another notable player in this space, has received support from Bezos and entrepreneur Peter Thiel.

These efforts highlight a growing interest in tackling the challenges of ageing and age-related diseases. The backing of tech visionaries and billionaires brings substantial financial resources and innovation to this emerging field.

With its ambitious goals and substantial financial support, Retro Biosciences is positioned as a key player in longevity. Its advancements in cell reprogramming and its determination to develop drugs targeting ageing-related diseases set it apart.

Altmanโ€™s financial commitment demonstrates his belief in the companyโ€™s vision and potential. As the biotech industry continues to explore groundbreaking ways to improve human health and extend life, Retro Biosciences will be watched to see if it can deliver on its promise to redefine healthy ageing in the years ahead.

Hot this week

Tenable reveals privilege escalation flaw in Google Cloud Run

Tenable uncovers a privilege escalation flaw in Google Cloud Run, exposing risks linked to inherited permissions and service interdependencies.

OpenAI set to finalise US$40 billion funding round led by SoftBank

According to Bloomberg, OpenAI is close to finalising a US$40 billion funding round led by SoftBank, which will raise its valuation to US$300 billion.

Chinese EV makers urged to expand globally despite tariff challenges

Chinese EV makers are urged to expand globally despite rising tariffs. Industry experts stress the need for overseas production and strategic partnerships.

Evento Seguro simplifies insurance access for event organisers in Brazil

Evento Seguro by Chubb makes event insurance easier for Brazilian organisers through a digital platform by Sympla and discovermarket.

Instagram introduces new speed-up feature for Reels

Instagram now lets you watch Reels at double speed, just like TikTok. The new feature helps you get through longer videos faster and easier.

Qualcomm expands AI research with MovianAI acquisition

Qualcomm has acquired Vietnamese AI research firm MovianAI to boost its AI development in smartphones, PCs, and software-defined vehicles.

Roblox introduces new parental controls to enhance child safety

Roblox introduces new parental controls, allowing parents to block games, restrict friends, and monitor their childโ€™s activity for better safety.

Anthropic introduces Claude for Education, a new AI chatbot plan for universities

Anthropic launches Claude for Education, an AI chatbot plan for universities that offers advanced learning tools and administration support.

Exabeam introduces Nova, an agentic AI that boosts cybersecurity operations

Exabeam unveils Nova, a proactive AI agent that boosts security team productivity and reduces incident investigation time by over 50%.

Related Articles